McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.
Hearst pumps $75M into Moffitt Cancer Center spinoff M2Gen
M2Gen, which has been around since 2006, and Moffitt are part of the Oncology Research Information Exchange Network alliance, which has 17 cancer center members that have access to a data warehouse linking clinical and molecular data.
presented by
Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies
Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.